Health Canada is introducing a new structure for the submission of device license information of class III and IV products following the INDRF Guidance on nIVD(MA)ToC.
As announced by Health Canada in its document 17-112120-288 a reduction of the audit time for MDSAP audits is suitable for small organizations to the following extent: 10% for <45 FTE 20% for <15 FTE